Trade TRAX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
First Tracks Biotherapeutics, Inc. (TRAX) is trading at US$39.57, down 5.33% today as of Sep 9, 16:00 EDT. The company has a market capitalisation of US$1.54B. Over the past 52 weeks, TRAX has traded between US$14.72 and US$49.91. On Syfe you can trade TRAX with $0 commission and add it to your watchlist.
| Previous close | US$41.80 |
|---|---|
| Market cap | US$1.54B |
| 52-week range | US$14.72 – US$49.91 |
| Volume | 478.54K |
| Exchange | US |
Add to Watchlist
Set Price Alert
First Tracks Biotherapeutics, Inc.
First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.
Year: 2026
UBS Adjusts First Tracks Biotherapeutics PT to $65 From $45, Maintains Buy Rating
Aug 10, 1:29 PM · MT Newswires
Wedbush Adjusts First Tracks Biotherapeutics Price Target to $60 From $30, Maintains Outperform Rating
Jul 27, 2:20 PM · MT Newswires
Top Premarket Gainers
Jul 27, 11:04 AM · MT Newswires
Wells Fargo Initiates First Tracks Biotherapeutics at Overweight
Jun 8, 9:28 AM · MT Newswires
First Tracks Biotherapeutics, Inc. (TRAX) stock is trading at US$39.57, -5.33% from the previous close of US$41.80.
The market cap for First Tracks Biotherapeutics, Inc. (TRAX) stock is approximately US$1.54B.
The 52-week high for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$49.91.
The 52-week low for First Tracks Biotherapeutics, Inc. (TRAX) stock is US$14.72.
First Tracks Biotherapeutics, Inc. (TRAX) does not currently pay a dividend.
Stay on top of TRAX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
